Probo Medical, a global leader in diagnostic imaging solutions, has announced that Mike Dilick will assume the role of Chief Executive Officer effective January 1, 2026, as the company seeks to accelerate growth and innovation.
Health Technology Insights: ZOLL Launches Fifth-Generation LifeVest WCD
Dilick has been with Probo Medical since 2018, serving as President and Chief Commercial Officer, where he played a key role in expanding the company’s commercial reach. With over 30 years of experience in diagnostic imaging, he brings extensive leadership expertise, strong industry relationships, and a deep commitment to supporting the company’s mission of advancing healthcare for those who care for others.
Dilick expressed his enthusiasm about taking on the role, saying he is honored to lead Probo forward and motivated to build on the company’s solid foundation as it enters its next stage of growth. He emphasized the importance of the company’s people and customers and highlighted his dedication to strengthening Probo’s impact in the diagnostic imaging industry.
Health Technology Insights: Datma and Rhythm Biosciences Partner on Genomic Data Collaboration
This leadership change reflects Probo Medical’s ongoing focus on operational excellence, improving the customer experience, and delivering reliable, high-quality imaging solutions that help healthcare providers deliver exceptional care.
Health Technology Insights: OsteoCentric Technologies Appoints Matthew Collier to Board of Directors
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
